The present invention relates to a cosmetic composition including an organic effect pigment. The organic effect pigment includes cellulose nanocrystal flakes which have an average size in the range of from 10 to 6500 micrometers.

A cosmetic activator system for activating a cosmetic is provided including: an activator having an energy source configured to emit an energy pulse and a controller; and an imprinter having an imprint pattern and at least one activation element configured to be in communication with the energy source, wherein the imprinter is configured to create an imprint on the cosmetic.

A cosmetic activator system for activating a cosmetic is provided including: an activator having an energy source configured to emit an energy pulse and a controller; and an imprinter having an imprint pattern and at least one activation element configured to be in communication with the energy source, wherein the imprinter is configured to create an imprint on the cosmetic.

A system and method includes a nonthermal plasma sub-system with a permeable UV filter for production and delivery of a redox gas solution to treat onychomycosis, wherein the redox gas solution comprises a reactive species dissolved in a perfluorocarbon liquid, and wherein the perfluorocarbon liquid is dispensed onto a gas-permeable membrane and wherein the reactive species may include, alone, or in combination, one or more of reactive oxygen, reactive nitrogen, reactive chlorine, or reactive bromine species, and the perfluorocarbon liquid may include perfluorodecalin.

A system and method includes a nonthermal plasma sub-system with a permeable UV filter for production and delivery of a redox gas solution to treat onychomycosis, wherein the redox gas solution comprises a reactive species dissolved in a perfluorocarbon liquid, and wherein the perfluorocarbon liquid is dispensed onto a gas-permeable membrane and wherein the reactive species may include, alone, or in combination, one or more of reactive oxygen, reactive nitrogen, reactive chlorine, or reactive bromine species, and the perfluorocarbon liquid may include perfluorodecalin.

The present disclosure discloses a method of manufacturing a semi-cured gel nail for nail art, and more particularly, to a method of manufacturing a UV-C semi-cured nail cured by being irradiated with ultraviolet of a UV-C wavelength. A gel nail according to an embodiment of the present disclosure may have a smooth surface on which luster is maintained and no fingerprint marks or traces remain even when the gel nail comes in contact with a hand or a device.

The present disclosure discloses a method of manufacturing a semi-cured gel nail for nail art, and more particularly, to a method of manufacturing a UV-C semi-cured nail cured by being irradiated with ultraviolet of a UV-C wavelength. A gel nail according to an embodiment of the present disclosure may have a smooth surface on which luster is maintained and no fingerprint marks or traces remain even when the gel nail comes in contact with a hand or a device.

The present invention relates to pre-formulations comprising low viscosity, non-liquid crystalline, mixtures of: a) at least one neutral diacyl lipid and/or at least one tocopherol; b) at least one phospholipid; c) at least one biocompatible, oxygen containing, low viscosity organic solvent;
wherein at least one bioactive agent is dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The preformulations are suitable for generating parenteral, non-parenteral and topical depot compositions for sustained release of active agents. The invention additionally relates to a method of delivery of an active agent comprising administration of a preformulation of the invention, a method of treatment comprising administration of a preformulation of the invention and the use of a preformulation of the invention in a method for the manufacture of a medicament.

The present invention relates to pre-formulations comprising low viscosity, non-liquid crystalline, mixtures of: a) at least one neutral diacyl lipid and/or at least one tocopherol; b) at least one phospholipid; c) at least one biocompatible, oxygen containing, low viscosity organic solvent;
wherein at least one bioactive agent is dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The preformulations are suitable for generating parenteral, non-parenteral and topical depot compositions for sustained release of active agents. The invention additionally relates to a method of delivery of an active agent comprising administration of a preformulation of the invention, a method of treatment comprising administration of a preformulation of the invention and the use of a preformulation of the invention in a method for the manufacture of a medicament.

The presently disclosed subject matter relates to a system for customizing a cosmetic product. The system includes: an interface device, in electronic communication with a single batch formulation device. The single batch formulation device is configured to formulate a customized cosmetic product, and a threaded container configured to be imported into the single batch formulation device containing a base and exported from the single batch formulation device containing the customized cosmetic.